Health
Convalescent plasma is still in demand. But there are caveats – ABC News
This is a Kaiser Health News story.
Six months after it was controversially hailed by Trump administration officials as a breakthrough therapy to fight the worst effects of covid-19, convalescent plasma appears to be on the ropes.
The treatment that infuses blood plasma from recovered covid patients into people newly infected in hopes of boosting their immune response has not lived up to early hype. Some high-profile clinical trials have shown disappointing results. Demand from hospitals for the…
-
Noosa News19 hours agoToyah Cordingley’s accused killer Rajwinder Singh had sand ‘scattered’ throughout car, Cairns court hears
-
General22 hours agoWait, which Haymarket Chinese Noodle restaurant is closing? – News + Articles
-
Noosa News21 hours agoLand care spreading far and wide
-
Noosa News24 hours agoInternational tourism strengthened | Noosa Today